[Guideline for adequate use of metabolic bone markers in osteoporosis].
Nishizawa
Yoshiki
Y
Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine.
Nakatsuka
Kiyoshi
K
D000469:Alkaline Phosphatase / Q000032:analysis*; D000596:Amino Acids / Q000032:analysis*; D015415:Biomarkers / Q000032:analysis; D015519:Bone Density; D003094:Collagen / Q000032:analysis*; D024042:Collagen Type I; D050723:Fractures, Bone / Q000517:prevention & control; D006801:Humans; D007349:Insurance, Health, Reimbursement; D007564:Japan; D010024:Osteoporosis / Q000175:diagnosis*; D010455:Peptides / Q000032:analysis*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D013048:Specimen Handling
D000596:Amino Acids; D015415:Biomarkers; D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; C036020:deoxypyridinoline; D003094:Collagen; D000469:Alkaline Phosphatase